Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
Amit M Oza, Adrian D Cook, Jacobus Pfisterer, Andrew Embleton, Jonathan A Ledermann, Eric Pujade-Lauraine, Gunnar Kristensen, Mark S Carey, Philip Beale, Andrés Cervantes, Tjoung-Won Park-Simon, Gordon Rustin, Florence Joly, Mansoor Raza Mirza, Marie Plante, Michael S Quinn, Andrés Poveda, Gordon C Jayson, Dan Stark, Ann Marie SwartLaura Farrelly, Richard Kaplan, Mahesh K B Parmar, Timothy J Perren, ICON7 trial investigators
Dive into the research topics of 'Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial'. Together they form a unique fingerprint.